Laurion Capital Management LP Lantheus Holdings, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$21.01 - $28.94 $239,682 - $330,147	-11,408 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$23.33 - $28.3 $266,148 - $322,846	11,408 New	11,408 $323,000
Q3 2018 Nov 13, 2018	SELL	$13.1 - $16.35 $218,770 - $273,045	-16,700 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$13.65 - $18.7 $227,955 - $312,290	16,700 New	16,700 $243,000
Q1 2018 May 14, 2018	SELL	$14.85 - $24.3 $206,415 - $337,770	-13,900 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$17.4 - $23.4 $241,859 - $325,260	13,900	13,900 $284,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.